| Scrip Code | 524715 |
|---|---|
| NSE Symbol | SUNPHARMA |
| MSEI Symbol | NOTLISTED |
| ISIN | INE044A01036 |
| Name of company | Sun Pharmaceutical Industries Limited |
| Type of company | Main Board |
| Class of security | Equity |
| Date of start of financial year | 01-04-2025 |
| Date of end of financial year | 31-03-2026 |
| Date of board meeting when results were approved | 22-05-2026 |
| Date on which prior intimation of the meeting for considering financial results was informed to the exchange | 11-05-2026 |
| Description of presentation currency | INR |
| Level of rounding used in financial results | Lakhs |
| Reporting Type | Quarterly |
| Reporting Quarter | Fourth quarter |
| Nature of report standalone or consolidated | Consolidated |
| Whether results are audited or unaudited for the quarter ended | Audited |
| Whether results are audited or unaudited for the Year to date for current period ended/year ended | Audited |
| Segment Reporting | Single segment |
| Description of single segment | Pharmaceuticals |
| Start date and time of board meeting | 22-05-2026 10:45:00 |
| End date and time of board meeting | 22-05-2026 16:00:00 |
| Whether cash flow statement is applicable on company | Yes |
| Type of cash flow statement | Cash Flow Indirect |
| Declaration of unmodified opinion or statement on impact of audit qualification | Declaration of unmodified opinion |
| Particulars | 3 months/ 6 months ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
|---|---|---|---|
| A | Date of start of reporting period | 01-01-2026 | 01-04-2025 |
| B | Date of end of reporting period | 31-03-2026 | 31-03-2026 |
| C | Whether results are audited or unaudited | Audited | Audited |
| D | Nature of report standalone or consolidated | Consolidated | Consolidated |
| 1 | Income | ||
| Revenue from operations | 14,61,179.00 | 58,46,204.00 | |
| Other income | 45,850.00 | 1,97,172.00 | |
| Total income | 15,07,029.00 | 60,43,376.00 | |
| 2 | Expenses | ||
| (a) | Cost of materials consumed | 2,18,244.00 | 7,38,902.00 |
| (b) | Purchases of stock-in-trade | 75,334.00 | 3,81,153.00 |
| (c) | Changes in inventories of finished goods, work-in-progress and stock-in-trade | (13,469.00) | 34,313.00 |
| (d) | Employee benefit expense | 2,96,041.00 | 11,41,886.00 |
| (e) | Finance costs | 8,589.00 | 33,891.00 |
| (f) | Depreciation, depletion and amortisation expense | 77,547.00 | 2,93,785.00 |
| (f) | Other Expenses | ||
| 1 | Other Expenses | 5,32,284.00 | 19,00,828.00 |
| 2 | Net (gain) / loss on foreign currency transactions | (42,675.00) | (1,24,018.00) |
| Total other expenses | 4,89,609.00 | 17,76,810.00 | |
| Total expenses | 11,51,895.00 | 44,00,740.00 | |
| 3 | Total profit before exceptional items and tax | 3,55,134.00 | 16,42,636.00 |
| 4 | Exceptional items | 0.00 | (1,30,748.00) |
| 5 | Total profit before tax | 3,55,134.00 | 15,11,888.00 |
| 6 | Tax expense | ||
| 7 | Current tax | 82,762.00 | 3,55,436.00 |
| 8 | Deferred tax | 0.00 | 0.00 |
| 9 | Total tax expenses | 82,762.00 | 3,55,436.00 |
| 10 | Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement | 0.00 | 0.00 |
| 11 | Net Profit Loss for the period from continuing operations | 2,72,372.00 | 11,56,452.00 |
| 12 | Profit (loss) from discontinued operations before tax | 0.00 | 0.00 |
| 13 | Tax expense of discontinued operations | 0.00 | 0.00 |
| 14 | Net profit (loss) from discontinued operation after tax | 0.00 | 0.00 |
| 15 | Share of profit (loss) of associates and joint ventures accounted for using equity method | (1,406.00) | (5,587.00) |
| 16 | Total profit (loss) for period | 2,70,966.00 | 11,50,865.00 |
| 17 | Other comprehensive income net of taxes | 1,50,337.00 | 3,82,674.00 |
| 18 | Total Comprehensive Income for the period | 4,21,303.00 | 15,33,539.00 |
| 19 | Total profit or loss, attributable to | ||
| Profit or loss, attributable to owners of parent | 2,71,403.00 | 11,47,942.00 | |
| Total profit or loss, attributable to non-controlling interests | (437.00) | 2,923.00 | |
| 20 | Total Comprehensive income for the period attributable to | ||
| Comprehensive income for the period attributable to owners of parent | 4,21,353.00 | 15,28,111.00 | |
| Total comprehensive income for the period attributable to owners of parent non-controlling interests | (50.00) | 5,428.00 | |
| 21 | Details of equity share capital | ||
| Paid-up equity share capital | 23,993.00 | 23,993.00 | |
| Face value of equity share capital | 1 | 1 | |
| 27 | Details of debt securities | ||
| 22 | Reserves excluding revaluation reserve | 83,33,016.00 | |
| 23 | Earnings per share | ||
| i | Earnings per equity share for continuing operations | ||
| Basic earnings (loss) per share from continuing operations | 11.3 | 47.8 | |
| Diluted earnings (loss) per share from continuing operations | 11.3 | 47.8 | |
| ii | Earnings per equity share for discontinued operations | ||
| Basic earnings (loss) per share from discontinued operations | 0 | 0 | |
| Diluted earnings (loss) per share from discontinued operations | 0 | 0 | |
| ii | Earnings per equity share | ||
| Basic earnings (loss) per share from continuing and discontinued operations | 11.3 | 47.8 | |
| Diluted earnings (loss) per share from continuing and discontinued operations | 11.3 | 47.8 | |
| 24 | Debt equity ratio | ||
| 25 | Debt service coverage ratio | ||
| 26 | Interest service coverage ratio | ||
| 27 | Disclosure of notes on financial results | Textual Information(1) | |
| Textual Information(1) | (1) For detailed notes refer full results uploaded on website of stock exchanges and company. (2) ) In cashflow, effect of exchange rate changes on cash and cash equivalents includes cash and cash equivalent taken over on acquisition of subsidiary of Rs. 1627.3 Mn |
|---|
| Debt equity ratio | |
|---|---|
| Debt service coverage ratio | |
| Interest service coverage ratio |
| Particulars | Year ended (dd-mm-yyyy) | |
|---|---|---|
| Date of start of reporting period | 01-04-2025 | |
| Date of end of reporting period | 31-03-2026 | |
| Whether results are audited or unaudited | Audited | |
| Nature of report standalone or consolidated | Consolidated | |
| Assets | ||
| 1 | Non-current assets | |
| Property, plant and equipment | 11,11,411.00 | |
| Capital work-in-progress | 1,38,065.00 | |
| Investment property | 0.00 | |
| Goodwill | 9,83,308.00 | |
| Other intangible assets | 11,87,508.00 | |
| Intangible assets under development | 1,67,108.00 | |
| Biological assets other than bearer plants | 0.00 | |
| Investments accounted for using equity method | 0.00 | |
| Non-current financial assets | ||
| Non-current investments | 3,78,907.00 | |
| Trade receivables, non-current | 0.00 | |
| Loans, non-current | 176.00 | |
| Other non-current financial assets | ||
| 1 | Other non-current financial assets | 6,661.00 |
| Total of other non-current financial assets | 6,661.00 | |
| Total non-current financial assets | 3,85,744.00 | |
| Deferred tax assets (net) | 4,04,646.00 | |
| Other non-current assets | ||
| 1 | Income tax assets (Net) | 64,513.00 |
| 2 | Other non-current assets | 47,100.00 |
| Total of other non-current assets | 1,11,613.00 | |
| Total non-current assets | 44,89,403.00 | |
| 2 | Current assets | |
| Inventories | 11,49,293.00 | |
| Current financial asset | ||
| Current investments | 20,93,345.00 | |
| Trade receivables, current | 15,50,967.00 | |
| Cash and cash equivalents | 9,77,051.00 | |
| Bank balance other than cash and cash equivalents | 1,83,257.00 | |
| Loans, current | 5,270.00 | |
| Other current financial assets | ||
| Total of other current financial assets | 1,40,369.00 | |
| Total current financial assets | 49,50,259.00 | |
| Current tax assets (net) | ||
| Other current assets | ||
| 1 | Other current assets | 2,86,477.00 |
| Total of other current assets | 2,86,477.00 | |
| Total current assets | 63,86,029.00 | |
| 3 | Non-current assets classified as held for sale | 3,090.00 |
| 4 | Regulatory deferral account debit balances and related deferred tax Assets | |
| Total assets | 1,08,78,522.00 | |
| Equity and liabilities | ||
| 1 | Equity | |
| Equity attributable to owners of parent | ||
| Equity share capital | 23,993.00 | |
| Other equity | 83,33,016.00 | |
| Total equity attributable to owners of parent | 83,57,009.00 | |
| Non controlling interest | 30,965.00 | |
| Total equity | 83,87,974.00 | |
| 2 | Liabilities | |
| Non-current liabilities | ||
| Non-current financial liabilities | ||
| Borrowings, non-current | 3,126.00 | |
| Trade payables, non-current | ||
| (A) Total outstanding dues of micro enterprises and small enterprises | ||
| (B) Total outstanding dues of creditors other than micro enterprises and small enterprises | ||
| Total Trade payable | ||
| Other non-current financial liabilities | ||
| 1 | Lease liabilities | 36,163.00 |
| 2 | Other non-current financial liabilities | 63,079.00 |
| Total of other non-current financial liabilities | 99,242.00 | |
| Total non-current financial liabilities | 1,02,368.00 | |
| Provisions, non-current | 51,218.00 | |
| Deferred tax liabilities (net) | 37,802.00 | |
| Deferred government grants, Non-current | ||
| Other non-current liabilities | ||
| 1 | Other non-current liabilities | 35,667.00 |
| 2 | Non-current tax liabilities (Net) | 1,289.00 |
| Total of other non-current liabilities | 36,956.00 | |
| Total non-current liabilities | 2,28,344.00 | |
| Current liabilities | ||
| Current financial liabilities | ||
| Borrowings, current | 4,05,035.00 | |
| Trade payables, current | ||
| (A) Total outstanding dues of micro enterprises and small enterprises | 0.00 | |
| (B) Total outstanding dues of creditors other than micro enterprises and small enterprises | 7,33,380.00 | |
| Total Trade payable | 7,33,380.00 | |
| Other current financial liabilities | ||
| 1 | Other current financial liabilities | 2,57,218.00 |
| 2 | Lease liabilities | 18,408.00 |
| Total of other current financial liabilities | 2,75,626.00 | |
| Total current financial liabilities | 14,14,041.00 | |
| Other current liabilities | 1,18,753.00 | |
| 1 | Other current liabilities | 1,18,753.00 |
| Total of other current liabilities | 1,18,753.00 | |
| Provisions, current | 5,94,406.00 | |
| Current tax liabilities (Net) | 1,35,004.00 | |
| Deferred government grants, Current | ||
| Total current liabilities | 22,62,204.00 | |
| 3 | Liabilities directly associated with assets in disposal group classified as held for sale | |
| 4 | Regulatory deferral account credit balances and related deferred tax liability | |
| Total liabilities | 24,90,548.00 | |
| Total equity and liabilites | 1,08,78,522.00 | |
| Disclosure of notes on assets and liabilities | ||
| Particulars | 3 months/ 6 month ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |||||
|---|---|---|---|---|---|---|---|
| Date of start of reporting period | 01-01-2026 | 01-04-2025 | |||||
| Date of end of reporting period | 31-03-2026 | 31-03-2026 | |||||
| Whether results are audited or unaudited | Audited | Audited | |||||
| Nature of report standalone or consolidated | Consolidated | Consolidated | |||||
| 1 | Segment Revenue (Income) | ||||||
| (net sale/income from each segment should be disclosed) | |||||||
| Total Segment Revenue | |||||||
| Less: Inter segment revenue | |||||||
| Revenue from operations | |||||||
| 2 | Segment Result | ||||||
| Profit (+) / Loss (-) before tax and interest from each segment | |||||||
| Total Profit before tax | |||||||
| i. Finance cost | |||||||
| ii. Other Unallocable Expenditure net off Unallocable income | |||||||
| Profit before tax | |||||||
| 3 | (Segment Asset - Segment Liabilities) | ||||||
| Segment Asset | |||||||
| Total Segment Asset | |||||||
| Un-allocable Assets | null | null | |||||
| Net Segment Asset | null | null | |||||
| 4 | Segment Liabilities | ||||||
| Segment Liabilities | |||||||
| Total Segment Liabilities | |||||||
| Un-allocable Liabilities | null | null | |||||
| Net Segment Liabilities | null | null | |||||
| Disclosure of notes on segments | |||||||
| Particulars | 3 months/ 6 months ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
|---|---|---|---|
| A | Date of start of reporting period | 01-01-2026 | 01-04-2025 |
| B | Date of end of reporting period | 31-03-2026 | 31-03-2026 |
| C | Whether results are audited or unaudited | Audited | Audited |
| D | Nature of report standalone or consolidated | Consolidated | Consolidated |
| Other comprehensive income [Abstract] | |||
| 1 | Amount of items that will not be reclassified to profit and loss | ||
| 1 | Items that will not be reclassified to profit or loss | (7,370.00) | 30,294.00 |
| Total Amount of items that will not be reclassified to profit and loss | (7,370.00) | 30,294.00 | |
| 2 | Income tax relating to items that will not be reclassified to profit or loss | 1,375.00 | 11,280.00 |
| 3 | Amount of items that will be reclassified to profit and loss | ||
| 1 | Items that may be reclassified to profit or loss | 1,55,939.00 | 3,56,440.00 |
| Total Amount of items that will be reclassified to profit and loss | 1,55,939.00 | 3,56,440.00 | |
| 4 | Income tax relating to items that will be reclassified to profit or loss | (3,143.00) | (7,220.00) |
| 5 | Total Other comprehensive income | 1,50,337.00 | 3,82,674.00 |
| Particulars | Year ended (dd-mm-yyyy) | |||||
|---|---|---|---|---|---|---|
| A | Date of start of reporting period | 01-04-2025 | ||||
| B | Date of end of reporting period | 31-03-2026 | ||||
| C | Whether results are audited or unaudited | Audited | ||||
| D | Nature of report standalone or consolidated | Consolidated | ||||
| Statement of cash flows | ||||||
| Cash flows from used in operating activities | ||||||
| Profit before tax | 15,11,888.00 | |||||
| Adjustments for reconcile profit (loss) | ||||||
| Adjustments for finance costs | 33,891.00 | |||||
| Adjustments for decrease (increase) in inventories | (5,230.00) | |||||
| Adjustments for decrease (increase) in trade receivables, current | (2,00,876.00) | |||||
| Adjustments for decrease (increase) in trade receivables, non-current | 0.00 | |||||
| Adjustments for decrease (increase) in other current assets | (20,956.00) | |||||
| Adjustments for decrease (increase) in other non-current assets | 0.00 | |||||
| Adjustments for other financial assets, non-current | 0.00 | |||||
| Adjustments for other financial assets, current | 0.00 | |||||
| Adjustments for other bank balances | 0.00 | |||||
| Adjustments for increase (decrease) in trade payables, current | 1,05,738.00 | |||||
| Adjustments for increase (decrease) in trade payables, non-current | 0.00 | |||||
| Adjustments for increase (decrease) in other current liabilities | 17,541.00 | |||||
| Adjustments for increase (decrease) in other non-current liabilities | 0.00 | |||||
| Adjustments for depreciation and amortisation expense | 2,93,785.00 | |||||
| Adjustments for impairment loss reversal of impairment loss recognised in profit or loss | 0.00 | |||||
| Adjustments for provisions, current | (22,996.00) | |||||
| Adjustments for provisions, non-current | 0.00 | |||||
| Adjustments for other financial liabilities, current | 0.00 | |||||
| Adjustments for other financial liabilities, non-current | 0.00 | |||||
| Adjustments for unrealised foreign exchange losses gains | (79,710.00) | |||||
| Adjustments for dividend income | 5,940.00 | |||||
| Adjustments for interest income | 91,500.00 | |||||
| Adjustments for share-based payments | 0.00 | |||||
| Adjustments for fair value losses (gains) | (87,610.00) | |||||
| Adjustments for undistributed profits of associates | 0.00 | |||||
| Other adjustments for which cash effects are investing or financing cash flow | 0.00 | |||||
| Other adjustments to reconcile profit (loss) | 0.00 | |||||
| Other adjustments for non-cash items | 25,287.00 | |||||
| Share of profit and loss from partnership firm or association of persons or limited liability partnerships | 0.00 | |||||
| Total adjustments for reconcile profit (loss) | (38,576.00) | |||||
| Net cash flows from (used in) operations | 14,73,312.00 | |||||
| Dividends received | 0.00 | |||||
| Interest paid | 0.00 | |||||
| Interest received | 0.00 | |||||
| Income taxes paid (refund) | 2,31,394.00 | |||||
| Other inflows (outflows) of cash | 0.00 | |||||
| Net cash flows from (used in) operating activities | 12,41,918.00 | |||||
| Cash flows from used in investing activities | ||||||
| Cash flows from losing control of subsidiaries or other businesses | 0.00 | |||||
| Cash flows used in obtaining control of subsidiaries or other businesses | 3,40,513.00 | |||||
| Other cash receipts from sales of equity or debt instruments of other entities | 26,16,741.00 | |||||
| Other cash payments to acquire equity or debt instruments of other entities | 30,80,406.00 | |||||
| Other cash receipts from sales of interests in joint ventures | 0.00 | |||||
| Other cash payments to acquire interests in joint ventures | 0.00 | |||||
| Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships | 0.00 | |||||
| Cash payment for investment in partnership firm or association of persons or limited liability partnerships | 0.00 | |||||
| Proceeds from sales of property, plant and equipment | 9,612.00 | |||||
| Purchase of property, plant and equipment | 3,60,937.00 | |||||
| Proceeds from sales of investment property | 0.00 | |||||
| Purchase of investment property | 0.00 | |||||
| Proceeds from sales of intangible assets | 0.00 | |||||
| Purchase of intangible assets | 0.00 | |||||
| Proceeds from sales of intangible assets under development | 0.00 | |||||
| Purchase of intangible assets under development | 0.00 | |||||
| Proceeds from sales of goodwill | 0.00 | |||||
| Purchase of goodwill | 0.00 | |||||
| Proceeds from biological assets other than bearer plants | 0.00 | |||||
| Purchase of biological assets other than bearer plants | 0.00 | |||||
| Proceeds from government grants | 0.00 | |||||
| Proceeds from sales of other long-term assets | 0.00 | |||||
| Purchase of other long-term assets | 0.00 | |||||
| Cash advances and loans made to other parties | 0.00 | |||||
| Cash receipts from repayment of advances and loans made to other parties | 0.00 | |||||
| Cash payments for future contracts, forward contracts, option contracts and swap contracts | 0.00 | |||||
| Cash receipts from future contracts, forward contracts, option contracts and swap contracts | 0.00 | |||||
| Dividends received | 5,940.00 | |||||
| Interest received | 70,466.00 | |||||
| Income taxes paid (refund) | 0.00 | |||||
| Other inflows (outflows) of cash | (55,308.00) | |||||
| Net cash flows from (used in) investing activities | (11,34,405.00) | |||||
| Cash flows from used in financing activities | ||||||
| Proceeds from changes in ownership interests in subsidiaries | 0.00 | |||||
| Payments from changes in ownership interests in subsidiaries | 380.00 | |||||
| Proceeds from issuing shares | 0.00 | |||||
| Proceeds from issuing other equity instruments | 0.00 | |||||
| Payments to acquire or redeem entity's shares | 0.00 | |||||
| Payments of other equity instruments | 0.00 | |||||
| Proceeds from exercise of stock options | 0.00 | |||||
| Proceeds from issuing debentures notes bonds etc | 0.00 | |||||
| Proceeds from borrowings | 5,32,207.00 | |||||
| Repayments of borrowings | 3,41,019.00 | |||||
| Payments of lease liabilities | 15,137.00 | |||||
| Dividends paid | 3,93,780.00 | |||||
| Interest paid | 33,146.00 | |||||
| Income taxes paid (refund) | 0.00 | |||||
| Other inflows (outflows) of cash | 0.00 | |||||
| Net cash flows from (used in) financing activities | (2,51,255.00) | |||||
| Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes | (1,43,742.00) | |||||
| Effect of exchange rate changes on cash and cash equivalents | ||||||
| Effect of exchange rate changes on cash and cash equivalents | 93,916.00 | |||||
| Net increase (decrease) in cash and cash equivalents | (49,826.00) | |||||
| Cash and cash equivalents cash flow statement at beginning of period | 10,26,877.00 | |||||
| Cash and cash equivalents cash flow statement at end of period | 9,77,051.00 | |||||
| Whether results are audited or unaudited | Audited |
|---|---|
| Declaration of unmodified opinion or statement on impact of audit qualification | Declaration of unmodified opinion |
| Auditor's opinion | |
| Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results | Yes |
| Sr No. | Audit firm's name | Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI | Certificate valid upto | ||
| 1 | S R B C & CO LLP | Yes | 28-02-2029 | ||
|---|---|---|---|---|---|